• Keeping Up With the Treatment Landscape for MDD

  • Aug 1 2023
  • Length: 29 mins
  • Podcast

Keeping Up With the Treatment Landscape for MDD

Listen for free

View show details

  • Summary

  • The treatment landscape of major depression is increasingly shifting from monoaminergic agents to agents that modulate glutamate and GABA. Healthcare professionals need to stay up to date and educated on these changes in order to discuss the most current treatment options with their patients. In this podcast episode, we interview Dr Anita Clayton, a clinician researcher who has been involved in some of the clinical trials for these novel glutamatergic and GABAergic medications, and ask her key questions about mechanism of action and clinical application. Listeners will come away from this podcast episode more informed and more excited for the future of major depression care. 

    Presenters:

    Anita Clayton, MD
    David C. Wilson Professor and Chair
    Department of Psychiatry and Neurobehavioral Sciences
    Professor of Clinical Obstetrics and Gynecology
    University of Virginia School of Medicine
    Charlottesville, Virginia

    This podcast episode is supported by an educational grant from Sage Therapeutics, Inc. and Biogen.

    Link to full program:
    https://bit.ly/3YdPMPa
    Show more Show less
Show more Show less

What listeners say about Keeping Up With the Treatment Landscape for MDD

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available